CC BY-NC-ND 4.0 · Asian J Neurosurg 2024; 19(02): 235-241
DOI: 10.1055/s-0044-1786699
Research Article

Variability of Resting Carbon Dioxide Tension in Patients with Intracranial Steno-occlusive Disease

Eric Plitman
1   Department of Anesthesia and Pain Management, University Health Network, University of Toronto, Toronto, Ontario, Canada
,
Lashmi Venkatraghavan
1   Department of Anesthesia and Pain Management, University Health Network, University of Toronto, Toronto, Ontario, Canada
,
Sanket Agrawal
1   Department of Anesthesia and Pain Management, University Health Network, University of Toronto, Toronto, Ontario, Canada
,
Vishvak Raghavan
2   Department of Computer Science, Faculty of Science, McGill University, Montreal, Quebec, Canada
,
Tumul Chowdhury
1   Department of Anesthesia and Pain Management, University Health Network, University of Toronto, Toronto, Ontario, Canada
,
Olivia Sobczyk
1   Department of Anesthesia and Pain Management, University Health Network, University of Toronto, Toronto, Ontario, Canada
,
3   Joint Department of Medical Imaging and the Functional Neuroimaging Laboratory, University Health Network, Toronto, ON, Canada
,
Julien Poublanc
3   Joint Department of Medical Imaging and the Functional Neuroimaging Laboratory, University Health Network, Toronto, ON, Canada
,
James Duffin
4   Department of Physiology, University of Toronto, Toronto, Ontario, Canada
,
David Mikulis
3   Joint Department of Medical Imaging and the Functional Neuroimaging Laboratory, University Health Network, Toronto, ON, Canada
,
Joseph Fisher
1   Department of Anesthesia and Pain Management, University Health Network, University of Toronto, Toronto, Ontario, Canada
› Author Affiliations
Funding This study was funded in part by a grant from MSH-UHN AMO AFP Innovation fund 2013-15.

Abstract

Introduction Controlling the partial pressure of carbon dioxide (PaCO2) is an important consideration in patients with intracranial steno-occlusive disease to avoid reductions in critical perfusion from vasoconstriction due to hypocapnia, or reductions in blood flow due to steal physiology during hypercapnia. However, the normal range for resting PCO2 in this patient population is not known. Therefore, we investigated the variability in resting end-tidal PCO2 (PETCO2) in patients with intracranial steno-occlusive disease and the impact of revascularization on resting PETCO2 in these patients.

Setting and Design Tertiary care center, retrospective chart review

Materials andMethods We collected resting PETCO2 values in adult patients with intracranial steno-occlusive disease who presented to our institution between January 2010 and June 2021. We also explored postrevascularization changes in resting PETCO2 in a subset of patients.

Results Two hundred and twenty-seven patients were included [moyamoya vasculopathy (n = 98) and intracranial atherosclerotic disease (n = 129)]. In the whole cohort, mean ± standard deviation resting PETCO2 was 37.8 ± 3.9 mm Hg (range: 26–47). In patients with moyamoya vasculopathy and intracranial atherosclerotic disease, resting PETCO2 was 38.4 ± 3.6 mm Hg (range: 28–47) and 37.4 ± 4.1 mm Hg (range: 26–46), respectively. A trend was identified suggesting increasing resting PETCO2 after revascularization in patients with low preoperative resting PETCO2 (<38 mm Hg) and decreasing resting PETCO2 after revascularization in patients with high preoperative resting PETCO2 (>38 mm Hg).

Conclusion This study demonstrates that resting PETCO2 in patients with intracranial steno-occlusive disease is highly variable. In some patients, there was a change in resting PETCO2 after a revascularization procedure.

Note

Controlling the partial pressure of carbon dioxide is an important consideration in perioperative neurosurgical care, as both hypocapnia and hypercapnia may lead to complications. This study shows that the resting (i.e., baseline) partial pressure of carbon dioxide in patients with intracranial steno-occlusive disease is highly variable and may be impacted by revascularization procedures. Further research is necessitated to improve our understanding of this phenomenon.


Prior Presentation

Organization: Canadian Anesthesiology Society Meeting


Place: Quebec City, Quebec. Canada


Date: June 10th, 2023


Authors' Contributions

E.P. contributed to conceptualization, experimental studies, data acquisition, and provided guarantee. L.V. helped in experimental studies. S.A. was involved in conceptualization, designing, literature search, clinical studies, experimental studies, data acquisition, statistical analysis, and provided guarantee. V.R., T.C., O.S., and E.S.S. contributed to conceptualization, designing, literature search, clinical studies, experimental studies, data analysis, statistical analysis, and provided guarantee. J.P., J.D., D.M., and J.F. helped in literature search and experimental studies and provided guarantee.


Ethical Approval

UHN REB # 22-5923, December 22, 2022


Data Availability Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.




Publication History

Article published online:
06 June 2024

© 2024. Asian Congress of Neurological Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Akça O. Optimizing the intraoperative management of carbon dioxide concentration. Curr Opin Anaesthesiol 2006; 19 (01) 19-25
  • 2 Brian Jr JE. Carbon dioxide and the cerebral circulation. Anesthesiology 1998; 88 (05) 1365-1386
  • 3 Sobczyk O, Battisti-Charbonney A, Fierstra J. et al. A conceptual model for CO2-induced redistribution of cerebral blood flow with experimental confirmation using BOLD MRI. Neuroimage 2014; 92: 56-68
  • 4 Arteaga DF, Strother MK, Faraco CC. et al. The vascular steal phenomenon is an incomplete contributor to negative cerebrovascular reactivity in patients with symptomatic intracranial stenosis. J Cereb Blood Flow Metab 2014; 34 (09) 1453-1462
  • 5 Zipfel GJ, Fox Jr DJ, Rivet DJ. Moyamoya disease in adults: the role of cerebral revascularization. Skull Base 2005; 15 (01) 27-41
  • 6 Kim SH, Choi JU, Yang KH, Kim TG, Kim DS. Risk factors for postoperative ischemic complications in patients with moyamoya disease. J Neurosurg 2005; 103 (05) , suppl): 433-438
  • 7 Michenfelder JD. Anesthesia for cerebral surgery. In: Stanley TH, Petty WC. eds. New Anesthetic Agents, Devices and Monitoring. 1st ed.. New York: Springer-Verlag; 1983: 45-49
  • 8 Deng RM, Liu YC, Li JQ, Xu JG, Chen G. The role of carbon dioxide in acute brain injury. Med Gas Res 2020; 10 (02) 81-84
  • 9 Messina Z, Patrick H. Partial Pressure of Carbon Dioxide. In: StatPearls. Treasure Island (FL): StatPearls; 2022
  • 10 Ito S, Mardimae A, Han J. et al. Non-invasive prospective targeting of arterial P(CO2) in subjects at rest. J Physiol 2008; 586 (15) 3675-3682
  • 11 Song T, Liu X, Han R, Huang L, Zhang J, Xu H. Effects of end-tidal carbon dioxide levels in patients undergoing direct revascularization for Moyamoya disease and risk factors associated with postoperative complications. Medicine (Baltimore) 2021; 100 (07) e24527
  • 12 Raghavan V, Sobczyk O, Sayin ES. et al. Assessment of Cerebrovascular Reactivity Using CO2 -BOLD MRI: A 15-Year, Single Center Experience. J Magn Reson Imaging 2023; (ahead of publication). DOI: 10.1002/jmri.29176.
  • 13 Slessarev M, Han J, Mardimae A. et al. Prospective targeting and control of end-tidal CO2 and O2 concentrations. J Physiol 2007; 581 (Pt 3): 1207-1219
  • 14 Somogyi RB, Vesely AE, Preiss D. et al. Precise control of end-tidal carbon dioxide levels using sequential rebreathing circuits. Anaesth Intensive Care 2005; 33 (06) 726-732
  • 15 Fisher JA, Iscoe S, Duffin J. Sequential gas delivery provides precise control of alveolar gas exchange. Respir Physiol Neurobiol 2016; 225: 60-69
  • 16 Sobczyk O, Battisti-Charbonney A, Poublanc J. et al. Assessing cerebrovascular reactivity abnormality by comparison to a reference atlas. J Cereb Blood Flow Metab 2015; 35 (02) 213-220
  • 17 Fierstra J, Winter JD, Machina M. et al. Non-invasive accurate measurement of arterial PCO2 in a pediatric animal model. J Clin Monit Comput 2013; 27 (02) 147-155
  • 18 Fierstra J, Machina M, Battisti-Charbonney A, Duffin J, Fisher JA, Minkovich L. End-inspiratory rebreathing reduces the end-tidal to arterial PCO2 gradient in mechanically ventilated pigs. Intensive Care Med 2011; 37 (09) 1543-1550
  • 19 Fisher JA. The CO2 stimulus for cerebrovascular reactivity: fixing inspired concentrations vs. targeting end-tidal partial pressures. J Cereb Blood Flow Metab 2016; 36 (06) 1004-1011
  • 20 Kurehara K, Ohnishi H, Touho H, Furuya H, Okuda T. Cortical blood flow response to hypercapnia during anaesthesia in Moyamoya disease. Can J Anaesth 1993; 40 (08) 709-713
  • 21 Kuwabara Y, Ichiya Y, Sasaki M. et al. Response to hypercapnia in moyamoya disease. Cerebrovascular response to hypercapnia in pediatric and adult patients with moyamoya disease. Stroke 1997; 28 (04) 701-707
  • 22 Ogawa A, Nakamura N, Yoshimoto T, Suzuki J. Cerebral blood flow in moyamoya disease. Part 2: Autoregulation and CO2 response. Acta Neurochir (Wien) 1990; 105 (3-4): 107-111
  • 23 Iwama T, Hashimoto N, Yonekawa Y. The relevance of hemodynamic factors to perioperative ischemic complications in childhood moyamoya disease. Neurosurgery 1996; 38 (06) 1120-1125
  • 24 Sato S, Kojima D, Shimada Y. et al. Preoperatively reduced cerebrovascular contractile reactivity to hypocapnia by hyperventilation is associated with cerebral hyperperfusion syndrome after arterial bypass surgery for adult patients with cerebral misery perfusion due to ischemic moyamoya disease. J Cereb Blood Flow Metab 2018; 38 (06) 1021-1031
  • 25 Fukuyama Y, Umezu R. Clinical and cerebral angiographic evolutions of idiopathic progressive occlusive disease of the circle of Willis (“moyamoya” disease) in children. Brain Dev 1985; 7 (01) 21-37
  • 26 Baykan N, Ozgen S, Ustalar ZS, Dagçinar A, Ozek MM. Moyamoya disease and anesthesia. Paediatr Anaesth 2005; 15 (12) 1111-1115
  • 27 Nomura S, Kashiwagi S, Uetsuka S, Uchida T, Kubota H, Ito H. Perioperative management protocols for children with moyamoya disease. Childs Nerv Syst 2001; 17 (4-5): 270-274
  • 28 Tagawa T, Naritomi H, Mimaki T, Yabuuchi H, Sawada T. Regional cerebral blood flow, clinical manifestations, and age in children with moyamoya disease. Stroke 1987; 18 (05) 906-910
  • 29 Chiu D, Shedden P, Bratina P, Grotta JC. Clinical features of moyamoya disease in the United States. Stroke 1998; 29 (07) 1347-1351
  • 30 Parray T, Martin TW, Siddiqui S. Moyamoya disease: a review of the disease and anesthetic management. J Neurosurg Anesthesiol 2011; 23 (02) 100-109
  • 31 Crosby A, Robbins PA. Variability in end-tidal PCO2 and blood gas values in humans. Exp Physiol 2003; 88 (05) 603-610
  • 32 Salinet ASM, Minhas JS, Panerai RB, Bor-Seng-Shu E, Robinson TG. Do acute stroke patients develop hypocapnia? A systematic review and meta-analysis. J Neurol Sci 2019; 402: 30-39
  • 33 Lee J, Kim SK, Kang HG. et al. High prevalence of systemic hypertension in pediatric patients with moyamoya disease years after surgical treatment. J Neurosurg Pediatr 2019; •••: 1-7
  • 34 Wallace JD, Levy LL. Blood pressure after stroke. JAMA 1981; 246 (19) 2177-2180
  • 35 McSwain SD, Hamel DS, Smith PB. et al. End-tidal and arterial carbon dioxide measurements correlate across all levels of physiologic dead space. Respir Care 2010; 55 (03) 288-293